The Effect of AI-based Microbiome Diet on IBS-M Symptoms

计划入组 25 人 · 首次发布于 2021 年 2 月 24 日

Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico

计划入组 55 人 · 首次发布于 2019 年 10 月 31 日

Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome

计划入组 71 人 · 首次发布于 2015 年 9 月 9 日

IBS-624

M-5291

M-121101

IBS-80, LLC

United States

BATEMAN, TIMOTHY M. M. MD

United States

TUMME IBS HEALTHCARE PTY LTD

Australia

Biomerica's inFoods IBS Test Shows Significant Pain Reduction in Clinical Trial, Particularly Effective for IBS-C and IBS-M Patients

Biomerica's inFoods IBS Test Shows 59% Response Rate in Real-World Study, Secures $300 Medicare Payment

Biomerica Appoints Scott Madel as Chief Commercial Officer to Drive inFoods IBS Test Commercialization